1. Home
  2. POET vs MANE Comparison

POET vs MANE Comparison

Compare POET & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POET Technologies Inc.

POET

POET Technologies Inc.

SELL

Current Price

$8.08

Market Cap

1.6B

Sector

Technology

ML Signal

SELL

MANE

Veradermics Incorporated Common Stock

N/A

Current Price

$96.85

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POET
MANE
Founded
1972
2019
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
POET
MANE
Price
$8.08
$96.85
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$83.33
AVG Volume (30 Days)
28.5M
550.5K
Earning Date
05-13-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$848.96
N/A
Revenue Next Year
$700.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.79
$36.26
52 Week High
$15.50
$101.81

Technical Indicators

Market Signals
Indicator
POET
MANE
Relative Strength Index (RSI) 50.17 70.69
Support Level $5.40 $54.23
Resistance Level $9.14 N/A
Average True Range (ATR) 1.37 8.17
MACD 0.20 1.87
Stochastic Oscillator 22.69 75.41

Price Performance

Historical Comparison
POET
MANE

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About MANE Veradermics Incorporated Common Stock

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Share on Social Networks: